vimarsana.com

Latest Breaking News On - Agnieszka blum - Page 1 : vimarsana.com

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Baden wübergMichael plattenEdward greenAgnieszka blumPrzemyslaw milosemailSee campaignEdward green research groupsHead of department brain tumor immunologyGerman cancer research centerHeidelberg universityArdimmune toxExecutive vice presidentBrain tumor immunologyMedical faculty mannheimGerman cancer researchDrug discovery

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Ardigen and DKFZ research groups are entering into a collaboration to evaluate the safety of TCR-based therapies (TCR-Ts)

Baden wübergMichael plattenEdward greenAgnieszka blumPrzemyslaw milosemailSee campaignEdward green research groupsHead of department brain tumor immunologyGerman cancer research centerHeidelberg universityArdimmune toxExecutive vice presidentBrain tumor immunologyMedical faculty mannheimGerman cancer researchDrug discovery

Mariola Fotin-Mleczek, PhD, has joined Ardigen s Scientific Board to support the drug discovery process for cancer immunology therapies

Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies.

Mariola fotin mleczekAgnieszka blumAnna klepackaemailTechnology officerSee campaignChief scientificChief technologyFor ardigenMarketing managertagsGoogle newsFinancial contentExtended distributionIcrowd news wireFor cancerHas joinedOtin mleczek

Mariola Fotin-Mleczek, PhD, has joined Ardigen s Scientific Board to support the drug discovery process for cancer immunology therapies

Mariola Fotin-Mleczek, PhD, has joined Ardigen’s Scientific Board to support the drug discovery process for cancer immunology therapies.

Mariola fotin mleczekAgnieszka blumAnna klepackaemailTechnology officerSee campaignChief scientificChief technologyFor ardigenMarketing managertagsGoogle newsFinancial contentExtended distribution

Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise

Agnieszka Blum, MD, PhD has been promoted to the Management Board of Ardigen to strengthen drug discovery expertise.

Janusz homaCharite universitAgnieszka blumAnna klepackaemailSee campaignMater misericordiae university hospitalGeneral directorImmunology business unitInternal medicineConsultant hematologistArdigen management boardDrug discoveryMarketing managertagsFinancial contentGoogle newsExtended distribution

vimarsana © 2020. All Rights Reserved.